Betaxolol recalls
The FDA has published 3 recalls involving Betaxolol since 2021. The latest was reported on 25 Oct 2023. Most were for sterility. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2021
Last 12 months0reported
Class I133% of total
Ongoing1latest 25 Oct 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 2 67%Class III 0 0%
Why betaxolol is recalled
Companies
By year
Ongoing betaxolol recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Betaxolol Ophthalmic Solution recalled by Akorn | Akorn | Manufacturing (CGMP) Deviations | Nationwide |
All betaxolol recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Betaxolol Tablets, USP 10 mg recalled by KVK-TechBetaxolol Hydrochloride | Kvk-Tech | Other | Nationwide |
| Drug | CLASS II | Betaxolol Ophthalmic Solution recalled by Akorn | Akorn | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Betaxolol Ophthalmic Solution recalled by Akorn | Akorn | Sterility | Nationwide |
Should you stop taking Betaxolol?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.